Novo Nordisk’s chief executive is preparing for a showdown next week with progressive firebrand Bernie Sanders over the high ...

SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

A class of drugs used to treat diabetes has been linked to a 20% lower risk of dementia and Parkinson's disease. | ...

Compounded semaglutide has emerged as a significant development in the management of obesity and type 2 diabetes. As a ...

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

Video game addiction, a growing concern for parents and healthcare professionals alike, is increasingly recognized as a ...

Timing is everything, right? Diabetes educators explain when they eat their first meal to manage their blood sugars.

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be ...

GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

Researchers discovered the crystal structure of an alternative DNA configuration within the insulin gene, providing insights ...